Clarithromycin Tablet, Film Coated
Product Images NDC 62332-344

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 62332-344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clarithromycin-250-mg.jpg (Clarithromycin 250 mg)

Clarithromycin-250-mg.jpg (Clarithromycin 250 mg)
Clarithromycin Tablets USP 250 mg film-coated oral tablets label by Alembic Pharmaceuticals Inc. The label states the quantity of 30 tablets per container, storage instructions, manufacturer information, and a barcode. It also includes the National Drug Code (NDC 62332-344-30) and warnings such as not accepting if the bottle seal is broken or missing.*
FDA Label Image

Clarithromycin-500-mg.jpg (Clarithromycin 500 mg)

Clarithromycin-500-mg.jpg (Clarithromycin 500 mg)
Clarithromycin Tablets, USP 500 mg film-coated oral tablets in a bottle label format. The label indicates a package size of 30 tablets, prescribed for oral use, and is marked RX only. It is manufactured and labeled by Alembic Pharmaceuticals Inc. and Alembic Pharmaceuticals Limited, with storage instructions and a barcode also visible.*
FDA Label Image

Figure 2 (Clarithromycin Figure2)

Figure 2 (Clarithromycin Figure2)
Line graph depicting mean plasma concentration (mcg/mL) over 24 hours after dosing. It compares Clarithromycin extended-release tablets (2 x 500 mg every 24 hours) and standard Clarithromycin tablets (500 mg every 12 hours), showing different plasma concentration profiles over time.*
FDA Label Image

Figure 3 (Clarithromycin Figure3)

Figure 3 (Clarithromycin Figure3)
A Kaplan-Meier survival curve comparing the proportion surviving over days since randomization between Clarithromycin and placebo groups. The graph shows survival probability on the y-axis versus days on the x-axis, illustrating survival trends for both groups over approximately 600 days.*
FDA Label Image

Structure (Clarithromycin Structure)

Structure (Clarithromycin Structure)
Chemical structure diagram of the active ingredient clarithromycin, showing its molecular configuration with various carbon, hydrogen, oxygen, and nitrogen atoms connected by bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.